Return to homepagePandemic Pact

Exploiting immunopathogenic mechanisms for establishing predictive markers, diagnostic tools and medical countermeasures in COVID-19

Grant number: COVID-2020- 12371817

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $988,445.51

  • Funder

    Ministry of Health - Italy

  • Principal Investigator

    Capobianchi Maria Rosaria

  • Research Location

    Italy

  • Lead Research Institution

    SPALLANZANI

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation.